Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses

Virology

Volumn 361, Issue 1, 2007, Pages 112-122

  Paul, Thomas A ^a   Casey, James W ^a   Avery, Roger J ^b   Sutton, Claudia A ^a  

^a C4 137 Veterinary Medical Center ^*  (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

APOBEC3G; FIV; FIV Oma; Lentivirus; Retrovirus; Vif; Virus mutation

Indexed keywords

APOLIPOPROTEIN B; CELL PROTEIN; DEOXYCYTIDINE; DEOXYURIDINE; HYBRID PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; DNA SEQUENCE; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; GENE REPLICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE; LENTIVIRINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; OTOCOLOBUS MANUL; PRIORITY JOURNAL; VIF GENE; VIRUS EXPRESSION; VIRUS GENE; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATS; CELL LINE; CODON; CYTOPLASM; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, VIF; IMMUNODEFICIENCY VIRUS, FELINE; MOLECULAR SEQUENCE DATA; TRANSFECTION; VIRUS REPLICATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MAMMALIA; OTOCOLOBUS MANUL;

EID: 34047266404     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.11.005     Document Type: Article

References (57)

1. Akari H., Fujita M., Kao S., Khan M.A., Shehu-Xhilaga M., Adachi A., and Strebel K. High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the Gag precursor at the p2/NC processing site. J. Biol. Chem. 279 (2004) 12355-12362
2. Audoly G., Sauze N., Harkiss G., Vitu C., Russo P., Querat G., Suzan M., and Vigne R. Identification and subcellular localization of the Q gene product of visna virus. Virology 189 (1992) 734-739
3. Barr M.C., Zou L., Holzschu D.L., Phillips L., Scotts F.W., Casey J.W., and Avery R.J. Isolation of a highly cytopathic lentivirus from a nondomestic cat. J. Virol. 69 (1995) 7371-7374
4. Barr M.C., Zou L., Long F., Hoose W.A., and Avery R.J. Proviral organization and sequence analysis of feline immunodeficiency virus isolated from a Pallas' cat. Virology 228 (1997) 84-91
5. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.-J., and Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14 (2004) 1392-1396
6. Blanc D., Patience C., Schulz T.F., Weiss R., and Spire B. Transcomplementation of Vif-HIV-1 mutants in CEM cells suggests that vif affects late steps of the viral life cycle. Virology 193 (1993) 186-192
7. Chatterji U., Grant C.K., and Elder J.H. Feline Immunodeficiency Virus Vif localizes to the nucleus. J. Virol. 74 (2000) 2533-2540
8. Conticello S.G., Harris R.S., and Neuberger M.S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr. Biol. 13 (2003) 2009-2013
9. Courcoul M., Patience C., Rey F., Blanc D., Harmache A., Sire J., Vigne R., and Spire B. Peripheral blood mononuclear cells produce normal amounts of Vif defective human immunodeficiency virus type 1 particles which are restricted for preretrotranscription steps. J. Virol. 69 (1995) 2069-2074
10. Fan L., and Peden K. Cell-free transmission of Vif mutants of HIV-1. Virology 190 (1992) 19-29
11. Fisher A.G., Ensoli B., Ivanoff L., Chamberlain M., Petteway S., Ratner L., Gallo R.C., and Wong-Staal F. The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science 237 (1987) 888-893
12. Fujita M., Akari H., Sakurai A., Yoshida A., Chiba T., Tanaka K., Strebel K., and Adachi A. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation. Microbes Infect. 6 (2004) 791-798
13. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W.A., and Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+T lymphocytes. J. Virol. 66 (1992) 6489-6495
14. Gabuzda D.H., Haodong L., Lawrence K., Vasir B.S., Cawford K., and Langhoff E. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocytes/macrophages. J. AIDS 7 (1994) 908-915
15. Gibbs J.S., Regier D.A., and Desrosiers R.C. Construction and in vitro properties of HIV-1 mutants with deletions in "non-essential" genes. AIDS Res. Hum. Retroviruses 10 (1994) 343-350
16. Gibbs J.S., Regier D.A., and Desrosiers R.C. Construction and in vitro properties of SIVmac mutants with deletions in "non-essential" genes. AIDS Res. Hum. Retroviruses 10 (1994) 333-342
17. Goncalves J., Jallepalli P., and Gabuzda D.H. Subcellular localization of the Vif protein of human immunodeficiency virus type 1. J. Virol. 68 (1994) 704-712
18. Goncalves J., Shi B., Yang X., and Gabuzda D. Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J. Virol. 69 (1995) 7196-7204
19. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., Hieblot C., Pepin M., Vigne R., and Suzan M. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 22 (1996) 246-255
20. Harris R.S., and Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. 4 (2004) 868-877
21. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., and Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 113 (2003) 803-809
22. Inoshima Y., Kohmoto M., Ikeda Y., Yamada H., Kawaguchi Y., Tomonaga K., Miyazawa T., Kai C., Umemura T., and Mikami T. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats. J. Virol. 70 (1996) 8518-8526
23. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., and Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79 (2002) 285-296
24. Kawakami T., Sherman L., Dahlberg J., Gazit A., Yaniv A., Tronick S.R., and Aaronson S.A. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology 158 (1987) 300-312
25. Kristbjornsdottir H.B., Andresdottir V., Svansson V., Torsteinsdottir S., Mattiasdottir S., and Andresson O.S. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro. Virology 318 (2004) 350-359
26. Lecossier D., Bouchonnet F., Clavel F., and Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300 (2003) 1112
27. Liddament M.T., Brown W.L., Schumacher A.J., and Harris R.S. APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo. Curr. Biol. 14 (2004) 1385-1391
28. Lockridge K.M., Himathongkham S., Sawai E.T., Chienand M., and Sparger E.E. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages. Virology 261 (1999) 25-30
29. Lochelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y.-B., Truyen U., Rosler U., Battenberg M., Saib A., Flory E., Cichutek K., and Munk C. The antiretroviral activity of APOBEC3 is inhibited by foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. 102 (2005) 7982-7987
30. Madani N., and Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72 (1998) 10251-10255
31. Maki N., Miyazawa T., Fukasawa M., Hasegawa A., Hayami M., Miki K., and Mikami T. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch. Virol. 123 (1992) 29-45
32. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., and Trono D. Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424 (2003) 99-103
33. Marin M., Rose K.M., Kozak S.L., and Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9 (2003) 1398-1403
34. Mehle A., Thomas E.R., Rajendran K.S., and Gabuzda D. A zinc-binding region in Vif binds Cul5 and determines cullin selection. J. Biol. Chem. 281 (2006) 17259-17265
35. Michaels F.H., Hattori N., Gallo R.C., and Franchini G. The Human immunodeficiency virus type 1 (HIV-1) Vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. AIDS Res. Hum. Retroviruses 9 (1993) 1025-1030
36. Nguyen K.-L., Llano M., Akari H., Miyagi E., Poeschla E.M., Strebel K., and Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 319 (2004) 163-175
37. Oberste M.S., and Gonda M.A. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes 6 (1992) 95-102
38. Poss M., Ross H.A., Painter S.L., Holley D.C., Terwee J.A., VandeWoude S., and Rodrigo A. Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase. J. Virol. 80 (2006) 2728-2737
39. Shacklett B.L., and Luciw P.A. Analysis of the vif gene of feline immunodeficiency virus. Virology 204 (1994) 860-867
40. Sheey A.M., Gaddis N.C., Choi J.D., and Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the Vif protein. Nature 418 (2002) 646-650
41. Sheehy A.M., Gaddis N.C., and Malim M.H. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9 (2003) 1404-1407
42. Shibata R., Adachi A., Sakai H., Ishimoto A., Miura T., and Hayami M. Mutational analysis of simian immunodeficiency virus from African green monkeys and human immunodeficiency virus type 2. J. Med. Primatol. 19 (1990) 217-225
43. Shirakawa K., Takaori-Kondo A., Kobayashi M., Tomonaga M., Izumi T., Fukunaga K., Sasada A., Abudu A., Miyauchi Y., Akari H., Iwai K., and Uchiyama T. Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. Virology 344 (2006) 263-266
44. Simon J.H.M., Southerling T.E., Peterson J.C., Meyer B.E., and Malim M.H. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69 (1995) 4166-4172
45. Simon J.H.M., Fouchier R.A.M., Southerling T.E., Guerra C.B., Grant C.K., and Malim M.H. The vif and gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J. Virol. 71 (1997) 5259-5267
46. Simon J.H.M., Gaddis N.C., Fouchier R.A.M., and Malim M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4 (1998) 1397-1400
47. Stopak K., de Noronha C., Yonemoto W., and Greene W.C. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12 (2003) 591-601
48. Strebel K., Daugherty D., Clouse K., Cohen D., Folks T., and Martin M.A. The HIV "A" (sor) gene product is essential for virus infectivity. Nature 328 (1987) 728-730
49. Tomonaga K., Norimine J., Shin Y.S., Fukasawa M., Miyaazawa T., Adachi A., Toyosaki T., Kawaguchi Y., Kai C., and Mikami T. Identification of a feline immunodeficnecy virus gene which is essential for cell-free virus infectivity. J. Virol. 66 (1992) 6181-6185
50. Wang H., Sakurai A., Khamsri B., Uchiyama T., Gu H., Adachi A., and Fujita M. Unique characteristics of HIV-1 Vif expression. Microbes Infect. 7 (2005) 385-390
51. Wiegand H.L., Doehle B.P., Bogerd H.P., and Cullen B.R. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J. 23 (2004) 2451-2458
52. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., and Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 (2003) 1056-1060
53. Yu Q., Chen D., Konig R., Mariani R., Unutmaz D., and Landau N.R. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279 (2004) 53379-53386
54. Yu Y., Xiao Z., Ehrlich S., Yu X., and Yu X.F. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18 (2004) 2867-2872
55. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 (2003) 94-98
56. Zheng Y.-H., Irwin D., Kurosu T., Tokunaga K., Sata T., and Peterlin B.M. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78 (2004) 6073-6076
57. Zou L., Barr M.C., Hoose W.A., and Avery R.J. Characterization of the transcription map and Rev activity of a highly cytopathic feline immunodeficiency virus. Virology 236 (1997) 266-278